Alphabet Inc. named Anat Ashkenazi as its new chief financial officer, replacing Ruth Porat who announced last year she would be stepping down from the role.
Private Equity’s Latest Move to Gin Up Cash: Borrowing Against Its Stock HoldingsAsset-Backed Debt Sales Reach $175 Billion in Bumper First HalfBond Traders Pile Into Fresh Bets on Faster Pace of Fed CutsDollar Tree Considering Sale, Spinoff of Family Dollar UnitUS Home-Purchase Applications Fall by Most Since Early AprilFund Managers Poised to Embark on ESG Purge Sparked by EU RulesECB Vets Banks’ Private Equity Risks as Industry Faces ReckoningPoland Will Keep Rates Steady on Wage...
stockpilesGermany to Buy 20 More Eurofighters in Military Expansion DriveColombian Companies Face Energy Crunch as Gas Reserves PlungeRoyal Mail’s Billionaire Buyer Loves Football Even More Than DealsChina’s Unusually Large Copper Stockpiles Fuel Demand ConcernsChina Risks Trade War on Two Fronts as Low-Tech Exports Soar, TooIndian Stock Futures Rise After Rout as Modi Vows to Hold PowerDutch May Pay as Much as €3 Billion to Clean Up Tata Steel PlantThe Daily Chase: Shopify shareholders set to...
Canada Latest News, Canada Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Britain Poised to Offer Eli Lilly’s Weight-Loss Drug to PatientsEli Lilly & Co.’s Mounjaro is being recommended for weight loss for some UK patients with obesity, in draft guidance that could see the National Health Service offer a rival drug to Novo Nordisk A/S’s hit treatment Wegovy.
Read more »
Eli Lilly commits $5.3B to up weight-loss drug productionEli Lilly and Company (LLY) announced today that it has committed more than $5.3 billion to its Lebanon, Indiana, manufacturing site, more than doubling its ...
Read more »
China Clears Eli Lilly’s Weight-Loss Drug, Only for Diabetes NowChina gave the greenlight to Eli Lilly & Co.’s blockbuster drug tirzepatide for use in treating diabetes, a move that will intensify the drugmaker’s rivalry with Novo Nordisk A/S over weight-loss drugs in the world’s second-largest market.
Read more »
Eli Manning Wants His Own Team as Private Equity Targets the NFLEli Manning, the retired quarterback who led the underdog New York Giants to two Super Bowl victories, now wants a team of his own.
Read more »
Eli Lilly reaches settlement with spa selling Mounjaro, Zepbound knockoffsExplore stories from Atlantic Canada.
Read more »
US FDA panel to discuss Eli Lilly Alzheimer's drug on June 10Explore stories from Atlantic Canada.
Read more »